Author

Jose Manuel Benitez 1

1 Hospital Universitario Reina Sofía and IMIBIC,Córdoba,Spain

EFFECTIVENESS AND SAFETY OF THE SWITCH FROM REMICADE<sup>®</sup> TO CT-P13 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Maria Chaparro Sanchez, A Garre, Maria Fernanda Guerra Veloz, J M Vázquez, M L De Castro, Eduardo Leo Carnerero, E Rodríguez, A Y Carbajo, Sabino Riestra Menéndez, I Jiménez, Xavier Calvet Calvo, Luis Bujanda, Montserrat Rivero, Fernando Gomollón, Jose Manuel Benitez, Fernando Bermejo, Noelia Alcaide, Ana Gutierrez Casbas;

Epidemiology, clinical characteristics, evolution and treatments in newly diagnosed inflammatory bowel disease (IBD): results from the nationwide EpidemIBD study of GETECCU

Maria Chaparro Sanchez, Manuel Barreiro-de Acosta, Jose Manuel Benitez, Jose Luis Cabriada, Maria José Casanova, Daniel Ceballos, María Esteve, Hipólito Fernández, Daniel Ginard, Fernando Gomollón, Rufo H. Lorente, Pilar Nos, Sabino Riestra, Montserrat Rivero, Pilar Robledo, Cristina Rodriguez, Beatriz Sicilia, Emilio Torr

EXTRACOLONIC NEOPLASIAS IN INFLAMMATORY BOWEL DISEASE PATIENTS: DATA FROM THE GETECCU ENEIDA REGISTRY

Maria Chaparro Sanchez, Jose Manuel Benitez, Alicia López-García, A. Juan, Jordi Guardiola Capon, Miguel Mínguez, Xavier Calvet Calvo, L Márquez, L Fernández-Salazar, L Bujanda, Antonio López San Román, Y Zabana, Rufo H. Lorente, J Barrio, E Hinojosa, Marisa Iborra, M Domínguez-Cajal, M. Van Domselaar, M F García-Sepulcre

EPIDEMIOLOGY, DIAGNOSTIC WORK-UP AND PHARMACOLOGICAL TREATMENTS OF INFLAMMATORY BOWEL DISEASE IN SPAIN: RESULTS FROM THE NATIONWIDE EPIDEMIBD STUDY OF GETECCU

Maria Chaparro Sanchez, Manuel Barreiro de-Acosta, Jose Manuel Benitez, Jose Luis Cabriada Nuño, María José Casanova González, Daniel Ceballos, Maria Esteve Comas, Hipolito Fernández Rosáenz, Daniel Ginard Vicens, Fernando Gomollón Garcia, Rufo Lorente Poyatos, Pilar Nos Mateu, Sabino Riestra Menéndez, Montserrat Rivero, Pila

METHOTREXATE AFTER ANTI-TNF-α FAILURE IN CROHN'S DISEASE: A RETROSPECTIVE SERIES FROM THE ENEIDA REGISTRY. TEACHING AN OLD DOG NEW TRICKS?

Francisco Mesonero, Jesus Castro Poceiro, Elena Ricart, Jose Manuel Benitez, Blau Camps Aler, Jordi Guardiola, Marisa Iborra, Alicia López-García, Paola Francesca Torres Rodríguez, María Esteve, Joan Tosca, Federico Bertoletti, Pedro Almela, Xavier Calvet, Maria Isabel Vera, Luis Bujanda, Fernando Gomollón Garcia, Cristina

SURGICAL AND HOSPITAL ADMISSION IN ADULTS NEWLY DIAGNOSED WITH INFLAMMATORY BOWEL DISEASE IN THE BIOLOGICAL ERA IN SPAIN: RESULTS OF THE NATIONWIDE EPIDEMIBD STUDY OF GETECCU

Maria Chaparro Sanchez, Manuel Barreiro de-Acosta, Jose Manuel Benitez, Jose Luis Cabriada, Maria José Casanova, Daniel Ceballos, Maria Esteve Comas, Hipolito Fernández Rosáenz, Daniel Ginard Vicens, Fernando Gomollón, Rufo Lorente Poyatos, Pilar Nos, Sabino Riestra Menéndez, Montserrat Rivero, Pilar Robledo, Cristina Rodrig

SNP RS6105269, A NEW PROGNOSIS MARKERS FOR CROHN DISEASE

Patricia Aguilar-Melero, Jose Manuel Benitez, Eva Iglesias, Rosario Medina Medina, Isabel Salgueiro, Maria Luisa Garcia, Valle García-Sánchez

Proteomic markers of response to anti-TNF drugs in Crohn´s disease

Rosario Medina Medina, Eva Iglesias Flores, Jose Manuel Benitez, Sandra Marín Pedrosa, Isabel Salgueiro Rodriguez, Gustavo Ferrín Sánchez, Clara I. Linares Luna, Sandra González Rubio, Pilar Soto Escribano, Beatriz Gros Alcalde, Cristina Moral, Francisco Álvarez, Manuel Rodríguez Perálvarez, Eduardo Chicano Gálvez, Ignacio Or

PROGNOSIS OF PATIENTS WITH ULCERATIVE COLITIS IN SUSTAINED REMISSION AFTER THIOPURINES WITHDRAWAL

Estefanía Moreno Rincón, Jose Manuel Benitez, Francisco Javier Serrano Ruiz, Juan Maria Vázquez Morón, Héctor Pallarés Manrique, José Manuel Herrera Justiniano, Eduardo Leo Carnerero, María Rosario Gómez García, María José Cabello Tapia, Manuel Castro Fernández, María Rojas Feria, Luisa Castro Laria, Federico Argüelles Arias,

Item 1 - 9 / 9
1
We use cookies in order to provide you with a better browsing experience. This includes third-party cookies for traffic analyzation purposes. See here for more information.
OK